Young Wendy B.
SEC CIK 2042847 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | Dir | 9,500 | $140.4K | — | 2 | 2025-03-12 | 2025-09-11 |
Most active insiders at RAPP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Third Rock Ventures V, L.P. | 10% | — | $34.39M |
| 2 | Ceesay Abraham | CEO, Dir | — | $6.07M |
| 3 | Yeleswaram Krishnaswamy | Chief Development Off | — | $4.46M |
| 4 | Bredt David | CSO | — | $1.36M |
| 5 | Gault Cheryl | COO | — | $906.4K |
Young Wendy B. made no open-market trades at RAPP in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-11 | 2025-09-11 | RAPP | Rapport Therapeutics, Inc. | Young Wendy B. | Dir | P - Purchase | $22.60 | +3,500 | 9,500 | +58% | +$79.1K | |
| 2025-03-13 | 2025-03-12 | RAPP | Rapport Therapeutics, Inc. | Young Wendy B. | Dir | P - Purchase | $10.21 | +6,000 | 6,000 | New | +$61.3K |
Purchase Sale Sale after option exercise All abbreviations